The future of cancer drug development looks pretty upbeat, going by news that some English scientists have found a new way to create man-made molecules, which is quite a feat considering that molecules are really miniscule things. This unlocks a whole array of possibilities, including creating new types of cancer drugs. Read on to find out more:


--------------------------------------------------


Scientists Reshape Future Of Drug Discovery With Next Generation Man-Made Molecules

ScienceDaily (Nov. 20, 2008) — A team from the Astbury Centre for Structural Molecular Biology at the University of Leeds has developed a new approach which allows the creation of molecules with an extraordinarily wide range of molecular frameworks and, hence, shapes. The new molecules are likely to have a wide range of biological functions, which means they could be valuable starting points for the discovery of new drugs.

Says lead researcher Professor Adam Nelson of the University's School of Chemistry: "Nature has created hundreds of thousands of molecules that have different frameworks and biological purposes, but in the global pursuit of new drugs, chemists from around the world are racing to create new molecules with functions not seen in nature."

Of the 30 million or so synthetic molecules made throughout the history of organic chemistry, many are based on an extremely small number of core frameworks, with the main differences being the groups attached at the periphery. "Making collections of similar molecules is great for optimising a biological property," says Professor Nelson, "but to put it simply, if researchers need a cube-shaped molecule to target a particular protein, they may well find that they can only choose from libraries stocked with millions of sphere-shaped ones."

Co-researcher Dr Stuart Warriner added: "Making molecules is a bit like making something using lego bricks. Up until now we've only really become good at making, say, the equivalent of a lego car or train. There might be 30 million synthetic molecules registered, but there's probably several million of these that are the equivalent of lego cars – they may have different wheels and wing mirrors, but their fundamental shape is essentially the same. We've not really scratched the surface of the possible structures that could be made. This lack of variety in the core shape of molecules may well limit the range of proteins that medicinal chemists can target."

Explains Professor Nelson: "We take simple building blocks, a bit like the amino acids that make up peptides, and we assemble them in different sequences using three simple reactions to link them together in a chain. The key difference is that we then add the catalyst which initiates a 'scaffold reprogramming reaction', which ripples down the chemical chain and restitches the molecule together in a completely different way each time.

"It's a bit like a molecular square dance, where atoms in the molecule swap partners - and the exciting thing is that we can change the building blocks again and again in different combinations as a really powerful way to vary the core frameworks that result. The potential of this process is enormous," he says.

Work has already begun across campus to screen the molecules, which are already yielding "promising" results. The team are considering patenting molecules with novel biological functions.

Source: Science Daily; http://www.sciencedaily.com/releases/2008/11/081119084239.htm

--------------------------------------------------


Let's hope that their work will yield fruitful results, and practical applications, thereby giving us newer and better medicines and drugs.

W.


This entry was posted on Friday, November 21, 2008 and is filed under . You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

0 comments: